This year's program will include the following sessions. Additional sessions and speakers will be added as they become final. For a full two-day timeline, visit the Schedule at a Glance.
Discipline of Supply Chain Logistics
This presentation will outline national supply chain issues regarding the pandemic and the recent changes in legislation on critical supply issues.
Rob Handfield, Ph.D. (North Carolina State University)
What is Sample Management?
At a fundamental level, sample management is about creating and fine-tuning efficient distribution networks while delivering a great experience to the users of the network. What can we learn and apply from other industries that specialize in distribution channels and customer service? Should we try to be the "Amazon" for the pharma industry? What architecture considerations need to be evaluated when setting up a network? This session will be an exploratory journey into the beautiful discipline of sample management.
Chair: Jose Quiroz (Bristol Myers Squibb)
Speaker: Alison Keelen (Bristol Myers Squibb)
Evolving the Compound Management Strategy — Developing a Distributed Operating Model Enabling Cross-Site Sample Management Capabilities
Speaker: Amanda Lembke (Amgen, Inc.)
A History of Sample Management at Amgen: How It Started, How It's Going, and All the People in Between
Speaker: Moana Simpson (Griffith University)
Lessons Learnt for Building a Sustainable Sample Management Resource in an Academic Environment
This point-counterpoint discussion will review the pros and cons of outsourcing and attempt to answer the questions:
Speaker: Michael Jobling, Ph.D. (Evotec)
Speaker: Sue Crimmin, Ph.D. (Pharma Discovery Logistics & Technology Consulting)
Speaker: Patrick Faloon, Ph.D., Principal Scientist (Biogen)
Emerging Technologies (Session One)
This session welcomes presentations from a wide range of technologies with potential applications in small and large molecule sample management in pre-clinical and clinical drug discovery, including innovations in consumables, laboratory automation, software concepts and applications.
Chair: Rose Gonzales, Ph.D. (Pfizer)
Speaker: Travis Mathewson, Ph.D. (Pfizer)
Adapting to the Latest Acoustic Technologies for Compound Management
Speaker: Lane Milde, Ph.D. (Pfizer)
Emerging Technologies that Enhance the Highly Automated Sample Management Laboratory
Speaker: Melissa Bennion (Biogen)
The Simplification of Requesting, Ordering, and Managing Your Sample Library
Speakers: Steve McCoy, Ph.D. (LabVoice)
Scientific Virtual Assistants: A New Generation of Sample Management Workflows
NEW! Join a roundtable discussion on the future of the Sample Management Special Interest Group. The Sample Management SIG Chairs are excited to use this opportunity to engage with YOU, the experts in the sample management world, to determine topics for future SIG meetings. This one-hour session is meant to be an open dialogue on what topics are important to you and what you would like to see discussed at the meeting during SLAS2022. This discussion is open to all attendees, and continental breakfast will be served.
*If you would like to be involved in leading a discussion roundtable during this meeting, please contact Mary Geismann.
Champions and Challenges of the Pandemic
The global pandemic gave sample management teams across the industry the opportunity to shine with creative solutions to operations and supply chain management. Sample Management teams typically rely heavily on automation, and the pandemic presented unique challenges to service, support, and new system commissioning. This session will highlight the roles compound management groups played during the pandemic in maintaining business continuity and adapting to sudden shifts in resources and staffing.
Chair: Duncan McNicol, Ph.D. (Merck & Co, Inc.)
Speaker: Susana A. Morais, Ph.D. (Merck & Co., Inc.)
Navigating Logistical Challenges During COVID-19 to Maintain Prioritized Program Productivity
Speaker: Christian Ferrante, Ph.D. (Bristol Myers Squibb)
Maintaining Compound Management Operations During the COVID-19 Pandemic: Keeping the Ship Sailing with a Skeleton Crew
Speaker: Brenda Li-Johnson, Ph.D. (GlaxoSmithKline)
Resilience in the Time of Pandemic: How we Overcame it and Became Stronger Sample Management
Speaker: Marianne K. Henderson, M.S., C.P.C. (Center for Global Health/National Cancer Institute/NIH/DHHS)
Mergers and Acquisitions
This panel discussion will review the lessons and pitfalls learned in mergers and acquisitions: What are strategies we can lean on? Is there a way to do it better? Our panelists will share their insight and experiences.
Speaker: Marybeth Burton, Ph.D. (Merck)
Speaker: David Hayes, Ph.D. (Specs)
Emerging Technologies (Session Two)
This session welcomes presentations from a wide range of technologies with potential applications in small and large molecule sample management in pre-clinical and clinical drug discovery, including innovations in consumables, laboratory automation, software concepts, and applications.
Chair: Kristen Nailor (Genentech)
Speaker: Jeff Chin (Pfizer)
Compound Confirmation During HTS using AE-OPI-MS
Speaker: Heather Colvan, Ph.D. (Simplicis)
Data Driven Sample Management
Speaker: Rob Perkinson (TMRW Life Sciences)
Presentation Title TBD